Skip to main navigation menu Skip to main content Skip to site footer
rd-24

Notes

Entre ajolotes y mascarillas

Importance of the microbiota for the immune response in COVID-19 infections: review of the keys to having a healthy microbiota.

Submitted
November 10, 2021
Published
September 15, 2021

Abstract

The study of the intestinal microbiota has grown exponentially in the last decade, and its importance in the human health-disease process is becoming evident. It has been implicated as mitigating the severity of many diseases, and this article reviewed its importance for the strength of the immune system and its response to SARS-CoV-2 infection. It was found that by enjoying a healthy microbiota, the inflammation that occurs in the body decreases and the effects caused by COVID-19 are diminished, allowing a better immune response to the virus. For this reason, conditions that can transgress the microbiota and how to restore the balance between the microbiota and the human being to maintain the health of the individual were pointed out.

References

  1. Aragón-Nogales, R., Vargas-Almanza, I., & Miranda-Novales, M. G. (2019). COVID-19 por SARS-CoV-2: la nueva emergencia de salud. Revista mexicana de pediatría, 86(6), 213-218.
  2. Biolab, I., España, D. I. D., & Usán, L. (2020). “ La microbiota puede ser útil en la valoración del pronóstico de la infección por COVID-19 .” 32–33.
  3. de Oliveira, G. L. V., Oliveira, C. N. S., Pinzan, C. F., de Salis, L. V. V., & Cardoso, C. R. D. B. (2021). Microbiota modulation of the gut-lung axis in COVID-19. Frontiers in Immunology, 12, 214.
  4. Dhar, D., & Mohanty, A. (2020). Gut microbiota and Covid-19-possible link and implications. Virus research, 198018.
  5. Dra, T. P. P. (2012). Visión panorámica del sistema inmune. Revista Médica Clínica Las Condes, 23(4), 446-457.
  6. Ferreira, C., Viana, S. D., & Reis, F. (2020). Gut microbiota dysbiosis–immune hyper response–inflammation triad in coronavirus disease 2019 (Covid-19): Impact of pharmacological and nutraceutical approaches. Microorganisms, 8(10), 1514.
  7. Ferrer, R. (2020). Pandemia por Covid-19: el mayor reto de la historia del intensivismo. Medicina intensiva, 44(6), 323.
  8. Finlay, B. B., Amato, K. R., Azad, M., Blaser, M. J., Bosch, T. C., Chu, H., ... & Giles-Vernick, T. (2021). The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proceedings of the National Academy of Sciences, 118(6).
  9. Gu, S., Chen, Y., Wu, Z., Chen, Y., Gao, H., Lv, L., ... & Li, L. (2020). Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clinical Infectious Diseases, 71(10), 2669-2678.
  10. Gou, W., Fu, Y., Yue, L., Chen, G. D., Cai, X., Shuai, M., ... & Zheng, J. S. (2020). Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. MedRxiv.
  11. Icaza-Chávez, M. E. (2013). Microbiota intestinal en la salud y la enfermedad. Revista de gastroenterología de México, 78(4), 240-248.
  12. Littlejohn, P., & Finlay, B. B. (2021). When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition. BMC medicine, 19(1), 1-8.
  13. López-Goñi, I. (2020). Microbioma humano: un universo en nuestro interior. Sociedad Española de Bioquímica y Biología Molecular.
  14. Molina-Molina, M. A. R. Í. A. (2020). Secuelas y consecuencias de la COVID-19. Medicina Respiratoria., 13, 71-77.
  15. Pérez Abreu, M. R., Gómez Tejeda, J. J., & Dieguez Guach, R. A. (2020). Características clínico-epidemiológicas de la COVID-19. Revista Habanera de Ciencias Médicas, 19(2).
  16. Perozo Mena, A. (2018). Editorial. Microbioma Humano. Kasmera, 46(2), 95–98.
  17. Rishi, P., Thakur, K., Vij, S., Rishi, L., Singh, A., Kaur, I. P., ... & Kalia, V. C. (2020). Diet, gut microbiota and COVID-19. Indian Journal of Microbiology, 1-10.
  18. Ruiz-Bravo, A., & Jiménez-Valera, M. (2020). SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19). Ars Pharmaceutica (Internet), 61(2), 63-79.
  19. Segal, J. P., Mak, J. W., Mullish, B. H., Alexander, J. L., Ng, S. C., & Marchesi, J. R. (2020). The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?. Therapeutic Advances in Gastroenterology, 13, 1756284820974914.
  20. Villapol, S. (2020). Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Translational Research.
  21. Yeoh, Y. K., Zuo, T., Lui, G. C. Y., Zhang, F., Liu, Q., Li, A. Y., ... & Ng, S. C. (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut, 70(4), 698-706.
  22. Zuo, T., Liu, Q., Zhang, F., Lui, G. C. Y., Tso, E. Y., Yeoh, Y. K., ... & Ng, S. C. (2021). Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut, 70(2), 276-284.
  23. Zuo, T., Zhang, F., Lui, G. C., Yeoh, Y. K., Li, A. Y., Zhan, H., ... & Ng, S. C. (2020). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology, 159(3), 944-955.